The role of KLF transcription factor in the regulation of cancer progression.

Kruppel-like factors (KLFs) are a family of zinc finger transcription factors that have been found to play an essential role in the development of various human tissues, including epithelial, teeth, and nerves. In addition to regulating normal physiological processes, KLFs have been implicated in promoting the onset of several cancers, such as gastric cancer, lung cancer, breast cancer, liver cancer, and colon cancer. To inhibit cancer progression, various existing medicines have been used to modulate the expression of KLFs, and anti-microRNA treatments have also emerged as a potential strategy for many cancers. Investigating the possibility of targeting KLFs in cancer therapy is urgently needed, as the roles of KLFs in cancer have not received enough attention in recent years. This review summarizes the factors that regulate KLF expression and function at both the transcriptional and posttranscriptional levels, which could aid in understanding the mechanisms of KLFs in cancer progression. We hope that this review will contribute to the development of more effective anti-cancer medicines targeting KLFs in the future.

Building a cobaloxime-based metal-organic framework for photocatalytic aerobic oxidation of arylboronic acids to phenols.

Herein, the design and synthesis of an unprecedented cobaloxime-based zirconium metal-organic framework (Zr-TCPCo) with an she net is reported. This heterogeneous material as a photocatalyst exhibits excellent catalytic activity for aerobic oxidation of arylboronic acids to phenols. Recycling experiments demonstrate the stability and reusability of Zr-TCPCo as a robust catalyst.

Stable Tetradentate Gold(III)-TADF Emitters with Close to Unity Quantum Yield and Radiative Decay Rate Constant of up to 2 × 106 s-1 : High-Efficiency Green OLEDs with Operational Lifetime (LT90 ) Longer than 1800 h at 1000 cd m-2.

High maximum external quantum efficiency (EQEmax ), small efficiency roll-offs, and long operational lifetime at practical luminances are three crucial parameters for commercialization of organic light-emitting diodes (OLEDs). To simultaneously achieve these goals, it is desirable to have the radiative decay rate constant (kr ) as large as possible, which, for a thermally activated delayed fluorescent (TADF) emitter, requires both a large S1 →S0 radiative decay rate constant (kr S ) and a small singlet-triplet energy gap (ΔEST ). Here, the design of a class of tetradentate gold(III) TADF complexes for narrowing the ΔEST while keeping the kr S large is reported. The as-synthesized complexes display green emission with close to unity emission quantum yields, and kr approaching 2 × 106 s-1 in thin films. The vacuum-deposited green OLEDs based on 1 and 4 demonstrate maximum EQEs of up to 24 and 27% with efficiency roll-offs of 5.5 and 2.2% at 1000 cd m-2 , respectively; the EQEs maintain high at 10 000 cd m-2 (19% (1) and 24% (4)). A long LT90 device lifetime of 1820 h at 1000 cd m-2 for complex 1 is achieved, which is one of the longest device lifetimes of TADF-OLEDs reported in the literature.

Integrin-mediated cancer progression as a specific target in clinical therapy.

Integrins, a group of heterodimer receptors for cell-matrix and cell-cell adhesion, mediate various intracellular activities, including cell migration, polarity, survival, growth, and death. Multiple types of integrins are differentially expressed in various cancers during different stages of progression, which are involved in the regulation of cancer cell proliferation, invasion, migration, and angiogenesis. The crucial roles of integrins in tumor progression provide valuable clues for cancer diagnosis and targeted therapy. Numerous integrin inhibitors have been investigated in clinical trials to explore effective regimens and minimize side effects. Given the complexity of the integrin-mediated tumor-promoting effect, challenges and difficulties remain in the research and development of integrin inhibitors, which seriously restrict the efficacy and application of integrin-targeted therapy. Novel targeted therapy of integrins, however, is beneficial for patients as a potential avenue forward, which needs better pharmacological effect, valid experimental models, and in-depth understanding of integrins. This review provides the insight needed to elucidate the mechanisms underlying cancer progression and novel protocols for the clinical treatment of cancer.

Ligand Tailoring Strategy of a Metal-Organic Framework for Optimizing Methane Storage Working Capacities.

Methane, as the main component of natural gas, shale gas, and marsh gas, is regarded as an ideal clean energy to replace traditional fossil fuels and reduce carbon emissions. Porous materials with superior methane storage capacities are the key to the wide application of adsorbed natural gas technology in vehicle transportation. In this work, we applied a ligand tailoring strategy to a metal-organic framework (NOTT-101) to fine-tune its pore geometry, which was well characterized by gas and dye sorption measurements. High-pressure methane sorption isotherms revealed that the methane storage performance of the modified NOTT-101 can be effectively improved by decreasing the unusable uptake at 5 bar and increasing the total uptake under high pressures, achieving a substantially high volumetric methane storage working capacity of 190 cm3 (STP) cm-3 at 298 K and 5-80 bar.